摘要
目的：分析腹腔镜手术下子宫肌瘤剔除的应用价值。方法：回顾性分析2008年1月至2011年12月武汉市中心医院就诊行腹腔镜下子宫肌瘤剔除术(Laparoscopic myomectomy, LM)145例,并与同期行开腹子宫肌瘤剔除术(Trans-abodominal myomectomy, TAM)435例患者比较其术中与术后情况。结果：两组患者临床特征无明显差异。腹腔镜手术剔除肌瘤个数为1个,2～4个及多于4个情况下,手术时间分别为73.89min、116.70min及162.41min,开腹组相应为75.40min、95.14min及123.33min。在术中出血量方面,肌瘤个数为1个,2～4个及多于4个情况下,分别为105.15ml、119.70ml及213.79ml,开腹组相应为142.90ml、164.44ml及191.11ml。对于单个肌瘤手术时间而言,腹腔镜手术与开腹手术相比,无论肌瘤部位及大小,两者均无明显差异。在术中出血量方面,单个肌壁间肌瘤及肌瘤直径在10cm以内单个肌瘤,腹腔镜手术少于开腹手术,差异具有统计学意义(P<0.05)。在术后恢复方面,腹腔镜组下床活动时间、通气时间及术后住院日等明显优于开腹组,差异具有统计学意义(P<0.05)。结论：腹腔镜子宫肌瘤剔除手术具有出血量少,术后恢复快的优势。
目的：分析腹腔镜手术下全子宫切除的临床应用安全性及优越性。方法：回顾性分析2008年1月至2011年12月武汉市中心医院就诊行腹腔镜全子宫切除术(Total laparoscopic hyeterectomy, TLH)218例,并与同期行开腹全子宫切除术(Trans-abodominal hyeterectomy, TAH)654例患者比较其术中与术后情况。结果：两组患者临床基本资料无明显差异。腹腔镜手术时间及术中失血量分别为75.78min及123.21ml,开腹组分别为96.62min及214.57ml,差异具有统计学意义。在术后恢复方面,腹腔镜组下床活动时间、通气时间及术后住院日等明显优于开腹组,差异具有统计学意义(P<0.05)。结论：腹腔镜子宫肌瘤剔除手术具有出血量少,术后恢复快的优势。
目的：分析腹腔镜手术治疗子宫内膜癌的临床应用安全性及优越性。方法：回顾性分析2008年1月至2011年12月武汉市中心医院因子宫内膜癌行腹腔镜下广泛全子宫切除术(Laparoscopic radical hyeterectomy, LRH)与盆腔淋巴结清扫术35例与同期行开腹广泛全子宫切除术(Abodominal radical hyeterectomy, ARH)35例,比较其术中、术后恢复情况及预后。结果：两组患者年龄、分期、病理类型等临床基本资料无明显差异。腹腔镜手术时间及术中失血量分别为227.35min及260.55ml,开腹组分别为230.65min及488.51ml,出血量差异有统计学意义。在术后恢复方面,腹腔镜组下床活动时间、通气时间及术后住院日等明显优于开腹组,差异具有统计学意义(P<0.05)。腔镜组发生尿潴留、伤口液化、淋巴囊肿等并发症分别为1例、0例、1例,开腹组分别为2例、2例、4例,差异有统计学意义。两组患者平均随访29个月(3-49个月),无复发生存率与总体生存率相近,差异无统计意义。结论：子宫内膜癌行腹腔镜下广泛全子宫切除术后恢复快、术后并发症少的优势。
目的：分析腹腔镜手术治疗宫颈癌的临床应用安全性及优越性。方法：回顾性分析2008年1月至2011年12月武汉市中心医院因宫颈癌行腹腔镜下广泛全子宫切除术(Laparoscopic radical hyeterectomy, LRH)与盆腔淋巴结清扫术55例与同期行开腹广泛全子宫切除术(Abodominal radical hyeterectomy, ARH)55例,比较其术中、术后恢复情况及预后。结果：两组患者年龄、分期、病理类型等临床基本资料无明显差异。腹腔镜手术时间及术中失血量分别为260.41min及266.76ml,开腹组分别为268.11min及479.73ml,出血量差异具有统计学意义。在术后恢复方面,腹腔镜组下床活动时间、通气时间及术后住院日等明显优于开腹组,差异具有统计学意义(P<0.05)。腔镜组发生尿潴留、伤口液化、淋巴囊肿等并发症分别为2例、0例、2例,开腹组分别为4例、3例、5例,差异有统计学意义。两组患者平均随访29个月(3-49个月),无复发生存率与总体生存率相近,差异无统计意义。结论：宫颈癌行腹腔镜下广泛全子宫切除术手术具有出血量少、术后恢复快、术后并发症少的优势。
Objective:To analyze the application of laparoscopic myoectomy in clinic. Methods:We analyzed surgeical outcome of 145 TAM and matched 435 LM performed from Jan 2008 to Dec 2011 in the center hospital of Wuhan. Results:The clinicl charecterisitc of the patients were similar in the two groups. The operating time of LM were 73.89min,116.70min and 162.41min, respectively while it was 75.40min,95.14min and 123.33min and the blood loss of LM was 105.15ml.119.70ml and 213.79ml respectively, while it was 142.90ml,164.44ml and 191.11ml in TAM according to the quantity of myoma in 1,2-4 and more than 4. The operating time was similar between the LM and TAM regardless the location and size of the myoma in single myoma. The blood loss of single intramurao fibroid and myoma diameter less than 10cm in LM was less than that in TAM. The time of off-bed activity, bowl function recover, hospital stay postoperative in LMs was better than that of TAM. Conclusion:LM has advantage in blood loss and postoperative recovery.
Objective:To analyze the application value of total laparoscopic hysterectomy in clinic. Methods:We analyzed surgeical outcome of 218 TLH and matched 654 TAH performed from Jan 2008 to Dec 2011 in the center hospital of Wuhan. Results:The clinicl charecterisitc of the patients were similar in the two groups. The operating time and blood loss was 75.78min and 123.21ml in TLH, which was 96.62min and 214.57ml (P<0.05). The time of off-bed activity, bowl function recover, hospital stay postoperative in TLH was better than that in TAH. Conclusion:TLH was a feasible procedure with an advantage of less blood loss, less operating time and postoperative recovery.
Objective:To analyze the application value of laparoscopic radical hysterectomy in patients with endometrial cancer. Methods:We retrospectively analyzed surgeical outcome and prognositic results between 35 endometrial cancer patients performed LRH and pelvic lymphadenectomy and matched 35 ARH from Jan 2008 to Dec 2011 in the center hospital of Wuhan. Results:The age, clinical stage and pathological type were similar between the two groups. The operating time and blood loss was 227.35min and 260.55ml in LRH, which was 230.65min and 488.51ml in ARH (P<0.05 in blood loss). The time of off-bed activity, bowl function recover, hospital stay postoperative in LRH was better than that in ARH (P<0.05). Postoperative complication was occurred in 2 patients in LRH,1 with urinary retention and 1 with lymphocyst, while there ware 2 patients with urinary retention,2 with lymphocyst and 4 with incision fat liquefaction in ARH. There was no differecnce in the disease-free survival and over survival after follow up for 3-49 months (average:29 months). Conclusion:LRH had an advantage of less time in postoperative recovery and less postoperative complication.
Objective:To analyze the application value of laparoscopic radical hysterectomy in patients with cervical cancer. Methods:We retrospectively analyzed surgeical outcome and prognostic results between 55 cervical cancer patients performed LRH and pelvic lymphadenectomy and matched 55 ARH from Jan 2008 to Dec 2011 in the center hospital of Wuhan. Results:The age, clinical stage and pathological type were similar between the two groups. The operating time and blood loss was 260.41min and 266.76ml in LRH, which was 268.11min and 479.73ml (P<0.05 in blood loss). The time of off-bed activity, bowl function recover, hospital stay postoperative in LRH was better than that in ARH (P<0.05). Postoperative complication was occurred in 4 patients in LRH,2 with urinary retention and 2 with lymphocyst, while there ware 4 patients with urinary retention,5 with lymphocyst and 3 with incision fat liquefaction in ARH. There was no differecnce in the disease-free survival and over survival after follow up for 3-49 months (average:29 months). Conclusion:LRH had an advantage of less blood loss, less time in postoperative recovery and less postoperative complication.
引文
1. Lemyre M, Bujold E. Lathi R, et al. Comparison of morbidity associated with laparoscopic myomectomy and hysterectomy for the treatment of uterine leiomyomas. J Obstet Gynaecol Can.2012; 34(1):57-62.
2. Kumakiri J, Kikuchi I, Kitade M, et al. Incidence of complications during gynecologic laparoscopic surgery in patients after previous laparotomy. J Minim Invasive Gynecol. 2010; 17(4):480-6.
3. Sami Walid M, Heaton RL.The role of laparoscopic myomectomy in the management of uterine fibroids. Curr Opin Obstet Gynecol.2011; 23(4):273-7.
4. Sinha R, Hegde A, Mahajan C, et al. Laparoscopic myomectomy:do size, number, and location of the myomas form limiting factors for laparoscopic myomectomy? J Minim Invasive Gynecol.2008; 15(3):292-300.
5. Sinha R, Sundaram M, Lakhotia S, et al. Total laparoscopic hysterectomy for large uterus. J Gynecol Endosc Surg.2009; 1(1):34-9.
6. Wen KC, Chen YJ, Sung PL, et al. Comparing uterine fibroids treated by myomectomy through traditional laparotomy and 2 modified approaches: ultraminilaparotomy and laparoscopically assisted ultraminilaparotomy. Am J Obstet Gynecol.2010; 202(2):144.el-8.
7. Tinelli A, Malvasi A, Hudelist G, et al. Laparoscopic intracapsular myomectomy: comparison of single versus multiple fibroids removal-An institutional experience. J Laparoendosc Adv Surg Tech A.2010; 20(8):705-11.
8. Zhang P, Song K, Li L, et al. Application of simultaneous morcellation in situ in laparoscopic myomectomy of larger uterine leiomyomas. Med Princ Pract.2011; 20(5):455-8.
9. Wang PH, Lee WL, Cheng MH, et al. Use of a gonadotropin-releasing hormone agonist to manage perimenopausal women with symptomatic uterine myomas. Taiwan J Obstet Gynecol.2009; 48(2):133-7.
10. Trehan N.Laparoscopic myomectomy:methods to control Blood. J Gynecol Endosc Surg.2011; 2(1):33-5.
11.张庆华.151例腹腔镜子宫肌瘤剔除术手术探讨[J].中国妇幼保健,2007,22.(18)：2541-2542.
1. Donnez O, Jadoul P, Squifflet J, et al. A series of 3190 laparoscopic hysterectomies for benign disease from 1990 to 2006:evaluation of complications compared with vaginal and abdominal procedures. BJOG.2009; 116(4):492-500.
2. Doganay M, Yildiz Y, Tongue E, et al. Abdominal, vaginal and total laparoscopic hysterectomy:perioperative morbidity. Arch Gynecol Obstet.2011; 284(2):385-9.
3. Candiani M, Izzo S, Bulfoni A,et al. Laparoscopic vs vaginal hysterectomy for benign pathology. Am J Obstet Gynecol.2009; 200(4):368.e1-7.
4. Chalermchockchareonkit A, Tekasakul P, Chaisilwattana P, et al. Laparoscopic hysterectomy versus abdominal hysterectomy for severe pelvic endometriosis. Int J Gynaecol Obstet.2012; 116(2):109-11.
5. Walsh CA, Walsh SR, Tang TY, et al. Total abdominal hysterectomy versus total laparoscopic hysterectomy for benign disease:a meta-analysis. Eur J Obstet Gynecol Reprod Biol.2009:144(1):3-7.
6. Papadopoulos MS, Tolikas AC, Miliaras DE. Hysterectomy-current methods and alternatives for benign indications. Obstet Gynecol Int.2010; 2010. pii:356740.
7. Sutasanasuang S. Laparoscopic hysterectomy versus total abdominal hysterectomy:a retrospective comparative study. J Med Assoc Thai.2011; 94(1):8-16.
8. Kondo W, Bourdel N, Marengo F, et al. Is laparoscopic hysterectomy feasible for uteri larger than 1000 g? Eur J Obstet Gynecol Reprod Biol.2011; 158(1):76-81.
9. Yada-Hashimoto N, Onoue M, Yoshimi K, et al.Total laparoscopic hysterectomy in patients with previous abdominal surgery. Arch Gynecol Obstet.2011; 284(6):1467-71.
10. Ayala-Yanez R, Briones-Landa C, Anaya-Coeto H, et al. Total laparoscopic hysterectomy:descriptive study of institutional experience with 198 cases]. Ginecol Obstet Mex.2010; 78(11):605-11.
11. Einarsson JI, Suzuki Y. Total laparoscopic hysterectomy:10 steps toward a successful procedure. Rev Obstet Gynecol.2009; 2(1):57-64.
12. Chalermchockchareonkit A, Tekasakul P, Chaisilwattana P, et al. Laparoscopic hysterectomy versus abdominal hysterectomy for severe pelvic endometriosis. Int J Gynaecol Obstet.2012; 116(2):109-11.
13. Twijnstra AR, Blikkendaal MD, van Zwet EW, et al. Predictors of successful surgical outcome in laparoscopic hysterectomy. Obstet Gynecol.2012; 119(4):700-8.
1. Pan XY, Lin H, Wang YN, et al. Feasibility of laparoscopic extraperitoneal pelvic lymphadenectomy in gynecologic malignancies. Gynecol Oncol.2011; 122(2):281-4.
2. Zhang H, Cui J, Jia L, et al. Comparison of laparoscopy and laparotomy for endometrial cancer. Int J Gynaecol Obstet.2012; 116(3):185-91.
3. Juhasz-Boss I, Haggag H, Baum S, et al. Laparoscopic and laparotomic approaches for endometrial cancer treatment:a comprehensive review. Arch Gynecol Obstet.2012; 25.
4. Barnett JC, Havrilesky LJ, Bondurant AE, et al. Adverse events associated with laparoscopy vs laparotomy in the treatment of endometrial cancer. Am J Obstet Gynecol.2011; 205(2):143.e1-6.
5. Ghezzi F, Uccella S, Cromi A, et al. Lymphoceles, lymphorrhea, and lymphedema after laparoscopic and open endometrial cancer staging. Ann Surg Oncol.2012; 19(1):259-67.
6. Spencer R, Schorge J, Del Carmen M, et al.Laparoscopic surgery for endometrial cancer:why don't all patients go home the day after surgery? J Minim Invasive Gynecol. 2012; 19(1):95-100.
7. Rabischong B, Larrain D, Canis M, et al. Long-term follow-up after laparoscopic management of endometrial cancer in the obese:a fifteen-year cohort study. J Minim Invasive Gynecol.2011; 18(5):589-96.
8. Helm CW, Arumugam C, Gordinier ME, et al. Laparoscopic surgery for endometrial cancer:increasing body mass index does not impact postoperative complications. J Gynecol Oncol.2011; 22(3):168-76.
9. ElSahwi KS, Hooper C, De Leon MC, et al. Comparison between 155 cases of robotic vs.150 cases of open surgical staging for endometrial cancer. Gynecol Oncol.2012: 124(2):260-4.
10. Kong TW, Lee KM, Cheong JY, et al. Comparison of laparoscopic versus conventional open surgical staging procedure for endometrial cancer. J Gynecol Oncol.2010; 21(2):106-11.
11. Mourits MJ, Bijen CB, Arts HJ, et al. Safety of laparoscopy versus laparotomy in early-stage endometrial cancer:a randomised trial. Lancet Oncol.2010; 11(8):763-71.
12. Ghezzi F, Cromi A, Uccella S, et al. Laparoscopic versus open surgery for endometrial cancer:a minimum 3-year follow-up study. Ann Surg Oncol.2010; 17(1):271-8.
13. Fader AN, Michener CM, Frasure HE, et al. Total laparoscopic hysterectomy versus laparoscopic-assisted vaginal hysterectomy in endometrial cancer:surgical and survival outcomes. J Minim Invasive Gynecol.2009; 16(3):333-9.
1. Donnez 0, Jadoul P, Squifflet J, et al. A series of 3190 laparoscopic hysterectomies for benign disease from 1990 to 2006:evaluation of complications compared with vaginal and abdominal procedures. BJOG.2009; 116(4):492-500.
2. Doganay M, Yildiz Y. Tonguc E. et al. Abdominal, vaginal and total laparoscopic hysterectomy:perioperative morbidity. Arch Gynecol Obstet.2011; 284(2):385-9.
3. Liang Z, Chen G, Xu H, et al. A model program for radical hysterectomy for cervical cancer:Asia Pacific perspective. Gynecol Oncol.2009; 114(2 Suppl):S37-44.
4. Sobiczewski P, Bidzinski M, Derlatka P, et al.Early cervical cancer managed by laparoscopy and conventional surgery:comparison of treatment results. Int J Gynecol Cancer.2009; 19(8):1390-5.
5. Fader AN, Edwards RP, Cost M, et al. Sentinel lymph node biopsy in early-stage cervical cancer:utility of intraoperative versus postoperative assessment. Gynecol Oncol.2008; 111(1):13-7.
6. Van de Lande J, von Mensdorff-Pouilly S, Lettinga RG, et al.Open versus laparoscopic pelvic lymph node dissection in early stage cervical cancer:no difference in surgical or disease outcome. Int J Gynecol Cancer.2012; 22(1):107-14.
7. Taylor SE, McBee WC Jr, Richard SD, et al. Radical hysterectomy for early stage cervical cancer:laparoscopy versus laparotomy. JSLS.2011; 15(2):213-7.
8. Nam JH, Park JY, Kim DY, et al. Laparoscopic versus open radical hysterectomy in early-stage cervical cancer:long-term survival outcomes in a matched cohort study. Ann Oncol.2012; 23(4):903-11.
9. Roy M, Bouchard-Fortier G, Popa I, et al. Value of sentinel node mapping in cancer of the cervix. Gynecol Oncol.2011; 122(2):269-74.
10. Yan X, Li G, Shang H, et al. Complications of laparoscopic radical hysterectomy and pelvic lymphadenectomy-experience of 117 patients. Int J Gynecol Cancer.2009; 19(5):963-7.
11. Pellegrino A, Vizza E, Fruscio R, et al. Total laparoscopic radical hysterectomy and pelvic lymphadenectomy in patients with Ibl stage cervical cancer:analysis of surgical and oncological outcome. Eur J Surg Oncol.2009; 35(1):98-103.
12. Malzoni M, Tinelli R, Cosentino F, et al. Total laparoscopic radical hysterectomy versus abdominal radical hysterectomy with lymphadenectomy in patients with early cervical cancer:our experience. Ann Surg Oncol.2009; 16(5):1316-23.
13. Lee EJ, Kang H, Kim DH. A comparative study of laparoscopic radical hysterectomy with radical abdominal hysterectomy for early-stage cervical cancer:a long-term follow-up study. Eur J Obstet Gynecol Reprod Biol.2011; 156(1):83-6.
14. Halaska MJ, Novackova M, Mala I, et al. A prospective study of postoperative lymphedema after surgery for cervical cancer. Int J Gynecol Cancer.2010; 20(5):900-4.
15. Yan X, Li G, Shang H, et al. Outcome and prognostic factors of laparoscopic radical hysterectomy and pelvic lymphadenectomy in 148 patients with stage IB1 cervical cancer. Int J Gynecol Cancer.2012; 22(2):286-90.
16.杜炜杰,刘金炜,陈利,等.腹腔镜两孔操作法在宫颈癌手术中的应用[J].中国内镜杂志,2010,16(7)：739-741.
1. Seracchioli R, Mabrouk M, Manuzzi L, et al. Role of laparoscopic hysterectomy in the management of endometrial cancer. Curr Opin Obstet Gynecol.2008; 20(4):337-44.
2. De la Orden SG, Reza MM, Blasco JA, et al. Laparoscopic hysterectomy in the treatment of endometrial cancer:a systematic review. J Minim Invasive Gynecol. 2008; 15(4):395-401.
3. Boruta DM, Growdon WB, McCann CK, et al. Evolution of surgical management of early-stage endometrial cancer.2011;205(6):565.e1-6.
4. Pan XY, Lin H, Wang YN,et al. Feasibility of laparoscopic extraperitoneal pelvic lymphadenectomy in gynecologic malignancies. Gynecol Oncol.2011; 122(2):281-4.
5. Zullo F, Falbo A, Palomba S. Safety of laparoscopy vs laparotomy in the surgical staging of endometrial cancer:a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol.2012 Jan 13.
6. Palomba S, Ghezzi F, Falbo A. et al. Laparoscopic versus abdominal approach to endometrial cancer:a 10-year retrospective multicenter analysis. Int J Gynecol Cancer. 2012;22(3):425-33.
7. Alan C. Schlaerth, Nadeem R, Abu-Rustum. Role of Minimally Invasive Surgery in Gynecologic Cancers. The Oncologist.2006; 11:895-901.
8. Joan L. Walker, Marion R. Piedmonte, Nick M, et al. Laparoscopy Compared With Laparotomy for Comprehensive Surgical Staging of Uterine Cancer:Gynecologic Oncology Group Study LAP2. J Clin Oncol.2009; 27:5331-5336.
9. Rabischong B. Larrain D, Canis M, et al. Long-term follow-up after laparoscopic management of endometrial cancer in the obese:a fifteen-year cohort study. J Minim Invasive Gynecol.2011; 18(5):589-96.
10. Helm CW, Arumugam C, Gordinier ME, et al. Laparoscopic surgery for endometrial cancer:increasing body mass index does not impact postoperative complications. J Gynecol Oncol.2011; 22(3):168-76.
11. Santi A, Kuhn A, Gyr T, Eberhard M, et al. Laparoscopy or laparotomy? A comparison of 240 patients with early-stage endometrial cancer. Surg Endosc.2010; 24(4):939-43.
12. Alice B. Kornblith, Helen Q. Huang, Joan L, et al. Quality of Life of Patients With Endometrial Cancer Undergoing Laparoscopic International Federation of Gynecology and Obstetrics Staging Compared With Laparotomy:A Gynecologic Oncology Group Study. J Clin Oncol.2009; 27:5337-5342.
13. Xiaojian Yan, Guangyi Li, Huilin Shang, et al. Complications of Laparoscopic Radical Hysterectomy and Pelvic Lymphadenectomy-Experience of 117 Patients. Int J Gynecol Cancer.2009; 19:963-967.
14. 王刚.腹腔镜广泛性子宫切除术严重并发症的防治[J].中国实用妇科与产科杂志.2011,27,(3)：169-171.
15. Obermair A, Manolitsas TP, Leung Y, et al. Total laparoscopic hysterectomy for endometrial cancer:patterns of recurrence and survival. Gynecol Oncol.2004; 92:789-793.
16. Fanfani F, Gagliardi ML, Zannoni GF, et al. Total laparoscopic hysterectomy in early-stage endometrial cancer using an intrauterine manipulator:is it a bias for frozen section analysis? Case-control study. J Minim Invasive Gynecol.2011; 18(2):184-8.
17. Roman Rouzier, Christophe Pomel. Update on the role of laparoscopy in the treatment of gynaecological malignancy. Curr Opin Obstet Gynecol.2005; 17:77-82.
18. Tozzi R, Malur S, Koehler C et al. Laparoscopy versus laparotomy in endometrial cancer:first analysis of survival of a randomized prospective study. J Minim Invasive Gynecol.2005; 12:130-136.
19. Ghezzi F, Cromi A, Uccella S, et al. Laparoscopic versus open surgery for endometrial cancer:a minimum 3-year follow-up study. Ann Surg Oncol.2010; 17(1):271-8.
20. Zhang H, Cui J, Jia L, et al. Comparison of laparoscopy and laparotomy for endometrial cancer. Int J Gynaecol Obstet.2012; 116(3):185-91.
21. Ball A, Bentley JR, O'Connell C, et al. Choosing the right patient:planning for laparotomy or laparoscopy in the patient with endometrial cancer. J Obstet Gynaecol Can.2011;33(5):468-74.
1 Jemal A, Bray F, Center MM et al. Global cancer statistics. CA Cancer J Clin [J], 2011,61(2):p.69-90.
2 Solomon D, Davey D, Kurman R et al. The 2001 Bethesda System:terminology for reporting results of cervical cytology. JAMA [J],2002,287(16):p.2114-9.
3梁爽,王彬,曹娇燕.538例宫颈非典型上皮细胞初筛结果分析.重庆医学[J],2009(22)：2858-2859.
4苏 玲.液基薄层细胞学配合阴道镜检查对宫颈病变的诊断价值.中国妇幼保健[J],2010(25)：3664-3665.
5朱晓玲, 李蓉,黄裕et al.P16及Ki67在子宫颈癌及癌前病变中的表达.重庆医学[J],2009(16)：204.
1 李晓兰.宫颈癌发病年轻化趋势分析[J].中国妇幼保健,2007,22(23)：3206
2孙成玲,周荣向,王莉et al.年轻妇女宫颈癌临床病理因素与预后的关系[J].中国全科医学,2010,13(10C)：3383
3 易为,李杏红,王建六et alEGFR、p16 (ink4a)在宫颈上皮内瘤变中的表达及与高危型HPV负荷量的关系[J].实用妇产科杂志,2010,26(9)：665
4林建龙,陈兰钦,刘启龙et al.P16(INK4A)、Ki-67及ER在宫颈病变病理诊断中的应用价值[J].中国妇幼保健,2010,25(31)：4593
5丁莉,邹先进,蔡兰et al.ELISA检测p16(INK4a)蛋白用于宫颈癌筛查方法建立及应用[J].中国实验诊断学,2010,14(10)：1632
6牛晓泉,李芹,车东媛et al.Ki67免疫组织化学定量分析在宫颈鳞状上皮内瘤变病理分级中的应用[J].华中科技大学学报(医学版),2010,39(4)：562
7朱晓玲,李蓉,黄裕et al.p16及Ki67在子宫颈癌及癌前病变中的表达[J].重庆医学,2009,38(16)：2041
1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011;61(2):69-90.
2. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System:terminology for reporting results of cervical cytology. JAMA 2002;287(16):2114-9.
3. The Bethesda System for reporting cervical/vaginal cytologic diagnoses. Report of the 1991 Bethesda Workshop. Am J Surg Pathol 1992; 16(9):914-6.
4. Wu S, Chen G, Wang W, et al. Value and feasibility of HPV DNA test in cervical scraping smears. J Huazhong Univ Sci Technolog Med Sci 2005;25(4):451-3,467.
5. Rappaport KM, Forrest CB, Holtzman NA. Adoption of liquid-based cervical cancer screening tests by family physicians and gynecologists. Health Serv Res 2004;39(4 Pt 1):927-47.
6. Levi AW, Harigopal M, Hui P, et al. Comparison of Affirm VPⅢ and Papanicolaou tests in the detection of infectious vaginitis. Am J Clin Pathol 2011;135(3):442-7.
7. Eriksson K, Adolfsson A, Forsum U, et al. The prevalence of BV in the population on the Aland Islands during a 15-year period. APMIS 2010; 118(11):903-8.
8. Delves PJ, Roitt IM. The immune system. First of two parts. N Engl J Med 2000;343(1):37-49.
9. Philip M, Rowley DA, Schreiber H. Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol 2004;14(6):433-9.
10. Ames BN, Gold LS, Willett WC. The causes and prevention of cancer. Proc Natl Acad Sci U S A 1995;92(12):5258-65.
11. Li S, Meng YH, Ting H, et al. Clinical significance of human papilloma virus infection in the cervical lesions. Front Med China 2010;4(3):264-70.
12. Cogliano V, Baan R, Straif K, et al. Carcinogenicity of human papillomaviruses. Lancet Oncol 2005;6(4):204.
13. Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med 2009;360(14):1385-94.
14. Sherman ME, Lorincz AT, Scott DR, et al. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia:a 10-year cohort analysis. J Natl Cancer Inst 2003;95(1):46-52.
15. Ortiz M, Torres M, Munoz L, et al. Oncogenic human papillomavirus (HPV) type distribution and HPV type 16 E6 variants in two Spanish population groups with different levels of HPV infection risk. J Clin Microbiol 2006;44(4):1428-34.
16. Wang H, Qiao YL. Human papillomavirus type-distribution in condylomata acuminata of mainland China:a meta-analysis. Int J STD AIDS 2008; 19(10):680-4.
17. Tsiodras S, Georgoulakis J, Chranioti A, et al. Hybrid capture vs. PCR screening of cervical human papilloma virus infections. Cytological and histological associations in 1270 women. BMC Cancer 2010;10:53.
18. Illades-Aguiar B, Alarcon-Romero Ldel C, Antonio-Vejar V, et al. Prevalence and distribution of human papillomavirus types in cervical cancer, squamous intraepithelial lesions, and with no intraepithelial lesions in women from Southern Mexico. Gynecol Oncol 2010;117(2):291-6.
19. Otero-Motta AP, Ordonez JL, Gonzalez-Celador R, et al. Prevalence of human papillomavirus genotypes in cytologic abnormalities from unvaccinated women living in north-western Spain. APMIS 2011;119(3):204-15.
20. Tabora N, Bulnes R, Toro LA.et al. Human papillomavirus infection in Honduran women with cervical intraepithelial neoplasia or cervical cancer. J Low Genit Tract Dis 2011;15(1):48-53.
21. Correnti M, Medina F, Cavazza ME, Rennola A, et al. Human papillomavirus (HPV) type distribution in cervical carcinoma, low-grade, and high-grade squamous intraepithelial lesions in Venezuelan women. Gynecol Oncol 2011.
22. Allameh T, Moghim S, Asadi-Zeidabadi M. A survey on the prevalence of high-risk subtypes of human papilloma virus among women with cervical neoplasia in Isfahan University of Medical Science. Arch Gynecol Obstet 2011.
23. Scheurer ME, Tortolero-Luna G, Adler-Storthz K. Human papillomavirus infection: biology, epidemiology, and prevention. Int J Gynecol Cancer 2005;15(5):727-46.
24. Wright TC, Jr., Massad LS, Dunton CJ, et al.2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis 2007;11(4):201-22.
25. Owens CL, Moats DR, Burroughs FH, et al. "Low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion" is a distinct cytologic category:histologic outcomes and HPV prevalence. Am J Clin Pathol 2007;128(3):398-403.
26. Wright TC, Jr., Schiffman M, Solomon D, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 2004;103(2):304-9.
27. Franco EL, Tota J. Invited commentary:Human papillomavirus infection and risk of cervical precancer--using the right methods to answer the right questions. Am J Epidemiol 2010; 171(2):164-8.
28. Franco EL, Olsen J, Saracci R, et al. Epidemiology's contributions to a Nobel Prize recognition. Epidemiology 2009;20(5):632-4.
29. Koss LG, Durfee GR. Unusual patterns of squamous epithelium of the uterine cervix: cytologic and pathologic study of koilocytotic atypia. Ann N Y Acad Sci 1956;63(6):1245-61.